Hematopoietic/Lymphoid Cancer Completed Phase Trials for Valganciclovir (DB01610)

IndicationStatusPhase
DBCOND0030132 (Hematopoietic/Lymphoid Cancer)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01199562Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantSupportive Care